Related Experiment Video
Updated: May 18, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Experimental chronic ocular hypertension by anterior chamber injection of 0.3% carbomer solution in the rat
Hwang-Gyun Kim1, Jung-Won Park, Sang-Woo Park
1Department of Ophthalmology, Chonnam National University Medical School and Hospital, Dong-gu, Gwangju, South Korea.
Background:
To evaluate a chronic ocular hypertensive model by anterior chamber injection of 0.3% carbomer solution in rats.
Methods:
Chronic ocular hypertension was induced unilaterally by injecting 20 μL of 0.3% carbomer solution into the anterior chamber in 3-month-old Sprague Dawley rats. Intraocular pressure was measured everyday for 1 week and then every week for 2 months after a single or repeated injection. Retinal ganglion cell loss was assessed quantitatively using FluoroGold labelling at 2, 4 and 8 weeks after injection. Anterior chamber angle and optic nerve were examined after chronic intraocular pressure elevation.
Results:
The mean and peak intraocular pressure of the injected eyes were elevated significantly higher than those of the control eyes for 6 weeks of the experiment, after a single injection of carbomer solution and a second injection at 2 weeks resulted in an 8-week elevation of the mean and peak intraocular pressure, which was significantly higher than those of the control eyes. Elevated intraocular pressure induced retinal ganglion cell loss by approximately 21%, 27% and 38% compared with that in the control eyes at 2, 4 and 8 weeks, respectively, after a single injection. In carbomer-injected eyes with chronic intraocular pressure elevation, the obstruction of anterior chamber angle by peripheral anterior synechia and optic nerve degeneration were observed.
Conclusions:
Anterior chamber injection of 0.3% carbomer solution was an effective and reproducible method to produce chronic intraocular pressure elevation and glaucomatous neurodegeneration in rats.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems

